-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's Pre-Market Session
Share
Listen to the news

Gainers

  • Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market session. The market value of their outstanding shares is at $112.9 million.
  • Barinthus Biotherapeutics (NASDAQ:BRNS) stock increased by 8.65% to $0.73. The company's market cap stands at $27.3 million.
  • Anteris Technologies Glb (NASDAQ:AVR) stock rose 7.67% to $8.98. The company's market cap stands at $811.8 million.
  • Genenta Science (NASDAQ:GNTA) shares increased by 7.63% to $1.55. The company's market cap stands at $33.7 million.
  • Jaguar Health (NASDAQ:JAGX) shares increased by 7.11% to $1.43. The company's market cap stands at $6.5 million.
  • Beyond Air (NASDAQ:XAIR) shares rose 7.02% to $5.94. The company's market cap stands at $3.9 million.

Losers

  • Regenxbio (NASDAQ:RGNX) shares fell 19.5% to $9.02 during Friday's pre-market session. The company's market cap stands at $579.0 million.
  • Liminatus Pharma (NASDAQ:LIMN) shares decreased by 17.0% to $0.12. The market value of their outstanding shares is at $9.9 million.
  • Kairos Pharma (AMEX:KAPA) stock declined by 15.86% to $0.29. The market value of their outstanding shares is at $7.2 million.
  • Agape ATP (NASDAQ:ATPC) shares decreased by 15.48% to $3.55. The company's market cap stands at $4.2 million.
  • Jasper Therapeutics (NASDAQ:JSPR) shares declined by 12.4% to $0.68. The company's market cap stands at $21.6 million.
  • Protalix BioTherapeutics (AMEX:PLX) stock decreased by 12.13% to $2.03. The market value of their outstanding shares is at $186.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending